Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice

Neuroscience Letters

Volumn 285, Issue 1, 2000, Pages 66-70

  Petitto, John M ^a,b   Streit, Wolfgang J ^b   Huang, Zhi ^a,b   Butfiloski, Ed ^b   Schiffenbauer, Joel ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Central nervous system; Cytokines; Demyelination; Gene deletion; Inflammation; Interleukin 2

Indexed keywords

INTERLEUKIN 2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DISEASE PREDISPOSITION; FEMALE; GENE DELETION; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HOMOZYGOTE; INTERLEUKIN-2; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 0034607616     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00996-4     Document Type: Article

References (20)

1. Duong T.T., Finkelman F.D., Strejan G.H. Effect of interferon-gamma on myelin basic protein-specific T cell line proliferation in response to antigen-pulsed accessory cells. Cell Immunol. 145:1992;311-323.
2. Eizenberg O., Faber-Elman A., Lotan M., Schwartz M. Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes. J. Neurochem. 64:1995;1928-1936.
3. Ferber I.A., Brocke S., Taylor E.C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:1996;5-7.
4. Grässl G., Pummerer C.L., Horak I., Neu N. Induction of autoimmune myocarditis in interleukin-2-deficient mice. Circulation. 95:1997;1773-1776.
5. Hanisch U.K., Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res. Rev. 21:1996;246-284.
6. Hollander G.A., Zuklys S., Morel C., Mizoguchi E., Mobisson K., Simpson S., Terhorst C., Wishart W., Golan D.E., Bhan A.K., Burakoff S.J. Monoallelic expression of the interleukin-2 locus. Science. 279:1998;2118-2121.
7. Horak I. Immunodeficiency in IL-2-knockout mice. Clin. Immunol. Immunopathol. 76:1995;172-173.
8. Jensen M.A., Arnason B.G., Toscas A., Noronha A. Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis. J. Autoimmun. 9:1996;587-597.
9. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
10. Kneitz B., Herrmann T., Yonehara S., Schimpl A. Normal clonal expansion but impaired Fas-mediated cell death and energy induction in interleukin-2-deficient mice. Eur. J. Immunol. 25:1995;2572-2577.
11. Kundig T.M., Schorle H., Bachmann M.F., Hengartner H., Zinkernagel R.M., Horak I. Immune responses in interleukin-2-deficient mice. Science. 262:1993;1059-1061.
12. Liblau R., Steinman L., Brocke S. Experimental autoimmune encephalomyelitis in IL-4 deficient mice. Int. Immunol. 9:1997;799-803.
13. Ludviksson B.R., Ehrhardt R.O., Strober W. TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J. Immunol. 159:1997;3622-3628.
14. McCombe P.A., Nickson I., Pender M.P. Cytokine expression by inflammatory cells obtained from the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein and adjuvants. J. Neuroimmunol. 88:1998;30-38.
15. Mendel I., Katz A., Kozak N., Ben N.A., Revel M. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1998;1727-1737.
16. Salmon M., Pilling D., Borthwick N.J., Viner N., Janossy G., Bacon P.A., Akbar A.N. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24:1994;892-899.
17. Samoilova E.B., Horton J.L., Hilliard B., Liu T.S., Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:1998;6480-6486.
18. Schiffenbauer J., Butfiloski E., Hanley G., Sobel E.S., Streit W.J., Lazarovits A. Prevention of experimental allergic encephalomyelitis by an antibody to CD45RB. Cell. Immunol. 190:1998;173-182.
19. Sivieri S., Ferrarini A.M., Gallo P. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of the literature and critical analysis of ELISA pitfalls. Mult. Scler. 4:1998;7-11.
20. Zettl U.K., Mix E., Zielasek J., Stangel M., Hartung H.P., Gold R. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell. Immunol. 178:1997;1-8.